US HB6705 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on December 11 2023 - 25% progression
Action: 2023-12-15 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 11 2023 - 25% progression
Action: 2023-12-15 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Secretary of Health and Human Services to treat certain tests for tuberculosis as breakthrough devices eligible for expedited development and priority review, to require certain establishments that perform donor screening or testing to screen or test for active and latent tuberculosis, and for other purposes.
Title
Effective Screening and Testing for Tuberculosis Act
Sponsors
Rep. John Moolenaar [R-MI] | Rep. Debbie Dingell [D-MI] | Rep. Luis Correa [D-CA] | Rep. Bill Huizenga [R-MI] |
History
Date | Chamber | Action |
---|---|---|
2023-12-15 | House | Referred to the Subcommittee on Health. |
2023-12-11 | House | Referred to the House Committee on Energy and Commerce. |
2023-12-11 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/6705/all-info |
Text | https://www.congress.gov/118/bills/hr6705/BILLS-118hr6705ih.pdf |